Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.
Journal: Cancer
Published: April 08, 2026
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 19, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 03, 2020
Showing 1-4 of 4
Last Updated: 09/26/2026